about
Unproven value of end-of-treatment FDG-PET in Hodgkin lymphoma.Assessing complete remission status in incurable follicular lymphomas, to what purpose?Interim FDG-PET in lymphoma, a questionable practice in hematology.Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma.Post-ABVD biopsy results, and not post-ABVD FDG-PET results, predict outcome in early-stage Hodgkin lymphoma.Diagnostic value of MRI signs in differentiating Ewing sarcoma from osteomyelitisValue of detecting bone marrow involvement in Hodgkin lymphomaSystematic review on the value of end-of-treatment FDG-PET in improving overall survival of lymphoma patientsAre Researchers Willing to Share Their Published Manuscript?Interim FDG-PET does not predict outcome in advanced-stage Hodgkin lymphoma patients treated with BEACOPP
P50
Q48127652-285ED643-50D0-42F4-A530-F8C3396D2A83Q48177120-E886BA42-A79E-4F00-A47D-286DEFB5AFDCQ48316502-D5E2BD9C-791A-43BE-8430-EE4850157DEFQ48349129-185BADC6-50E2-47F0-B1B0-54D9544FAB3BQ48371831-16FAE83E-5053-4F3C-9DE2-742057E6E8FCQ88616952-58376D70-5988-4A82-B68C-700CDA930BD1Q90122421-0862B5F3-2008-46CA-8DC0-FF2BB5EB2010Q91769137-DED7C331-6260-4439-B992-CB8658DC5E7AQ91837335-EB2D48C8-6D66-439B-8665-A9F166712177Q93086899-5D6B3DCC-645D-441D-8A0B-96422FF3367E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Hugo J A Adams
@en
Hugo J A Adams
@nl
type
label
Hugo J A Adams
@en
Hugo J A Adams
@nl
prefLabel
Hugo J A Adams
@en
Hugo J A Adams
@nl
P31
P496
0000-0003-1049-7607